Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting.

Siccardi M, DʼAvolio A, Rodriguez-Novoa S, Cuenca L, Simiele M, Baietto L, Calcagno A, Moss D, Bonora S, Soriano V, Back DJ, Owen A, Di Perri G.

Ther Drug Monit. 2012 Apr;34(2):232-5. doi: 10.1097/FTD.0b013e31824aa50a.

PMID:
22406652
2.

[Pharmacokinetics and interactions of raltegravir].

Placeres Alsina MM, Tuset Creus M, Miró JM.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:23-8. Review. Spanish.

PMID:
19572422
3.

Clinical pharmacology profile of raltegravir, an HIV-1 integrase strand transfer inhibitor.

Brainard DM, Wenning LA, Stone JA, Wagner JA, Iwamoto M.

J Clin Pharmacol. 2011 Oct;51(10):1376-402. doi: 10.1177/0091270010387428. Epub 2011 Jan 5. Review.

PMID:
21209233
4.

[Pharmacology, pharmacokinetic features and interactions of atazanavir].

López-Cortés LF.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:2-8. doi: 10.1016/S0213-005X(08)76613-8. Review. Spanish.

PMID:
20116610
5.

Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.

Culley CL, Kiang TK, Gilchrist SE, Ensom MH.

Ann Pharmacother. 2013 Apr;47(4):561-72. doi: 10.1345/aph.1R550. Epub 2013 Apr 2. Review.

PMID:
23548653
6.

Raltegravir: the first HIV integrase inhibitor.

Cocohoba J, Dong BJ.

Clin Ther. 2008 Oct;30(10):1747-65. doi: 10.1016/j.clinthera.2008.10.012. Review.

PMID:
19014832
7.

Role of raltegravir in HIV-1 management.

Rokas KE, Bookstaver PB, Shamroe CL, Sutton SS, Millisor VE, Bryant JE, Weissman SB.

Ann Pharmacother. 2012 Apr;46(4):578-89. doi: 10.1345/aph.1Q616. Epub 2012 Apr 10. Review.

PMID:
22496475
8.

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele.

Panagopoulos P, Maltezos E, Hatzakis A, Paraskevis D.

Pharmgenomics Pers Med. 2017 Jun 20;10:205-208. doi: 10.2147/PGPM.S107152. eCollection 2017. Review.

9.

UGT1A1 Mediated Drug Interactions and its Clinical Relevance.

Goon CP, Wang LZ, Wong FC, Thuya WL, Ho PC, Goh BC.

Curr Drug Metab. 2016;17(2):100-6. Review.

PMID:
26526830

Supplemental Content

Support Center